Identification of Genetic Factors that Modify Clinical Onset of Huntington’s Disease

Lee, Jong-Min, Wheeler, Vanessa C., Chao, Michael J., Vonsattel, Jean Paul G., Pinto, Ricardo Mouro, Lucente, Diane, Abu-Elneel, Kawther, Ramos, Eliana Marisa +19 more·2015·Cell

Cited by (659)

Items 601–659 of 659

  1. Additional file 12 of Machine learning in Huntington’s disease: exploring the Enroll-HD dataset for prognosis and driving capability prediction
    Jasper Ouwerkerk, Stephanie Feleus, Kasper F. van der Zwaan, Yunlei Li, Marco Roos, Willeke van Roon‐Mom, Susanne Tamara de Bot, Katherine Wolstencroft, Eleni Mina · 2023 · Figshare
  2. Additional file 3 of Machine learning in Huntington’s disease: exploring the Enroll-HD dataset for prognosis and driving capability prediction
    Jasper Ouwerkerk, Stephanie Feleus, Kasper F. van der Zwaan, Yunlei Li, Marco Roos, Willeke van Roon‐Mom, Susanne Tamara de Bot, Katherine Wolstencroft, Eleni Mina · 2023 · Figshare
  3. Additional file 10 of Machine learning in Huntington’s disease: exploring the Enroll-HD dataset for prognosis and driving capability prediction
    Jasper Ouwerkerk, Stephanie Feleus, Kasper F. van der Zwaan, Yunlei Li, Marco Roos, Willeke van Roon‐Mom, Susanne Tamara de Bot, Katherine Wolstencroft, Eleni Mina · 2023 · Figshare
  4. Additional file 9 of Machine learning in Huntington’s disease: exploring the Enroll-HD dataset for prognosis and driving capability prediction
    Jasper Ouwerkerk, Stephanie Feleus, Kasper F. van der Zwaan, Yunlei Li, Marco Roos, Willeke van Roon‐Mom, Susanne Tamara de Bot, Katherine Wolstencroft, Eleni Mina · 2023 · Figshare
  5. Additional file 7 of Machine learning in Huntington’s disease: exploring the Enroll-HD dataset for prognosis and driving capability prediction
    Jasper Ouwerkerk, Stephanie Feleus, Kasper F. van der Zwaan, Yunlei Li, Marco Roos, Willeke van Roon‐Mom, Susanne Tamara de Bot, Katherine Wolstencroft, Eleni Mina · 2023 · Figshare
  6. Additional file 8 of Machine learning in Huntington’s disease: exploring the Enroll-HD dataset for prognosis and driving capability prediction
    Jasper Ouwerkerk, Stephanie Feleus, Kasper F. van der Zwaan, Yunlei Li, Marco Roos, Willeke van Roon‐Mom, Susanne Tamara de Bot, Katherine Wolstencroft, Eleni Mina · 2023 · Figshare
  7. Additional file 6 of Machine learning in Huntington’s disease: exploring the Enroll-HD dataset for prognosis and driving capability prediction
    Jasper Ouwerkerk, Stephanie Feleus, Kasper F. van der Zwaan, Yunlei Li, Marco Roos, Willeke van Roon‐Mom, Susanne Tamara de Bot, Katherine Wolstencroft, Eleni Mina · 2023 · Figshare
  8. Huntington's Disease
    Michael Murphy, Mena Farag, Sarah J. Tabrizi · 2024 · Elsevier eBooks
  9. Using gene or cell therapies to treat Huntington's disease
    Caroline S. Binda, Mariah J. Lelos, Anne Rosser, Thomas H. Massey · 2024 · Handbook of clinical neurology
  10. The TRX assay for triplet repeat expansions
    Thomas O’Brien, Karolina Salciute, Shaylee R. Kieffer, Nehaa K. P. Ponraj, Madeleine Richer, Paulina Marzec, Caroline Benn, Darren G. Monckton, Vincent Dion, Robert S. Lahue · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  11. CellPHIE: Integrating Pathway Discovery With Pooled Profiling of Perturbations Uncovers Pathways of Huntington’s Disease, Including Genetic Modifiers of Neuronal Development and Morphology
    Byunguk Kang, Michael A. Murphy, Christopher Ng, Matthew Joseph Leventhal, Nhan C. Huynh, Egun Im, Serwah A. Danquah, David E. Housman, Ralda Nehme, Samouil L. Farhi et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  12. Education Level and Huntington's Disease Progression: A Retrospective Cohort Analysis in Western China
    Sirui Zhang, Yangfan Cheng, Lingyu Zhang, Yuanzheng Ma, Jiajia Fu, Tianmi Yang, Jieqiang Xia, Chunyu Li, Jean‐Marc Burgunder, Huifang Shang · 2025 · Movement Disorders Clinical Practice
  13. Fluid and Imaging Markers of Huntington’s Disease
    Mena Farag, Rachael I. Scahill, Edward J. Wild, Sarah J. Tabrizi · 2025 · Springer eBooks
  14. USP7 deubiquitinase stabilizes FAN1 to support DNA crosslink repair and suppress CAG repeat expansion
    Giulio Collotta, Maurizio Gatti, Irina-Maria Ungureanu, Vanessa van Ackeren, Emilie Rannou, Francesca Vivalda, Diego Gomez Vieito, Keri M. Fishwick, Christine von Aesch, Antônio Porro et al. · 2026 · Nature Communications
  15. Dietary patterns and fasting behaviors in Huntington's disease population: A cross-sectional survey study
    Russell G. Wells, Lee E. Neilson, Amie Hiller · 2025 · Nutrition and Health
  16. Connecting HTT intermediate alleles and microRNA dysregulation to enhanced tauopathy in late-onset Alzheimer’s disease
    Juan Castilla‐Silgado, Sergio Pérez‐Oliveira, Paola Pinto-Hernández, Manuel Fernández‐Sanjurjo, María Daniela Corte-Torres, Olaya Fernandez-Alvarez, Eduardo Iglesias‐Gutiérrez, Manuel Menéndez‐González, Victoria Álvarez, Cristina Tomás‐Zapico · 2026 · Alzheimer s Research & Therapy
  17. Inhibiting Cytosine-Adenine-Guanine (CAG) repeat expansions as a therapeutic strategy for Huntington’s disease
    Raymond J. Winquist, Bruce Church · 2025 · Biochemical Pharmacology
  18. Case 21: Huntington’s Disease with Atypical Onset
    Silvia Daniela Morbelli, Giulia Ferrarazzo · 2025 · Springer eBooks
  19. Direct Measure of DNA Damage in Huntington Disease Reveals Elevated Oxidative Genotoxic Stress and Dysfunctional DNA Repair
    Carlos Barba Bazan, Samantha R Laville-Dupuy, Maya Klepfish, J. Cousineau, Tamara Maiuri, Christina Yi Peng, Elizabeth J. Osterlund, Melanie Alpaugh, Ray Truant · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  20. Striatal pathology in Spinocerebellar Ataxia Type 1 mice: A comparative study with Huntington’s disease
    Pragya Goel, Praseuth Yang, Lisa A. Duvick, Orion Rainwater, Shannah Serres, Brennon L. O’Callaghan, Rocío Gómez‐Pastor, Mustafa Hussain Mehkary, Terence Gall-Duncan, Peter Langfelder et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  21. Additional file 1 of Psychiatric morbidity and poor follow-up underlie suboptimal functional and survival outcomes in Huntington’s disease
    Nikhil Ratna, Nitish L. Kamble, Sowmya Devatha Venkatesh, Meera Purushottam, Pal, Pramod K., Jain, Sanjeev · 2020 · Figshare
  22. Additional file 4 of Machine learning in Huntington’s disease: exploring the Enroll-HD dataset for prognosis and driving capability prediction
    Jasper Ouwerkerk, Stephanie Feleus, Kasper F. van der Zwaan, Yunlei Li, Marco Roos, van Roon-Mom, Willeke M. C., Susanne Tamara de Bot, Katherine Wolstencroft, Eleni Mina · 2023 · Figshare
  23. Additional file 5 of Machine learning in Huntington’s disease: exploring the Enroll-HD dataset for prognosis and driving capability prediction
    Jasper Ouwerkerk, Stephanie Feleus, Kasper F. van der Zwaan, Yunlei Li, Marco Roos, van Roon-Mom, Willeke M. C., Susanne Tamara de Bot, Katherine Wolstencroft, Eleni Mina · 2023 · Figshare
  24. Additional file 1 of Machine learning in Huntington’s disease: exploring the Enroll-HD dataset for prognosis and driving capability prediction
    Jasper Ouwerkerk, Stephanie Feleus, Kasper F. van der Zwaan, Yunlei Li, Marco Roos, van Roon-Mom, Willeke M. C., Susanne Tamara de Bot, Katherine Wolstencroft, Eleni Mina · 2023 · Figshare
  25. Mismatch repair MLH complexes make distinct contributions to post-replicative mismatch repair versus trinucleotide repeat expansions
    K. Casazza, Gregory M. Williams, Lauren Johengen, Maxwell Keller, Luke D. Hess, Samantha Phelps, Natalie A. Lamb, Jennifer A. Surtees · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  26. Huntington’s disease LIG1 modifier variant increases ligase fidelity and suppresses somatic CAG repeat expansion
    Eunhye Lee, Wonju Kim, David H. Beier, Yejin Lee, Marina V. Kovalenko, Faaiza Saif, Esaria Oliver, Bhairavi Srinageshwar, Ryan Murtha, Marissa A Andrew et al. · 2026 · Proceedings of the National Academy of Sciences
  27. Large-scale Perturbation of Systems Biology-Derived Genes Reveals Modifiers of HD- associated Transcriptomic Networks and Pathology
    Peter Langfelder, Nan Wang, Lalini Ramanathan, Young Mi Oh, Seongwon Lee, Fuying Gao, Xiaofeng Gu, Matthew Stricos, Mary Plascencia, Raymond Vaca et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  28. Reconstitution du réseau corticostriatal et cible thérapeutique dans la maladie de Huntington
    Amandine Virlogeux · 2018 · theses.fr (ABES)
  29. Rôle des altérations transcriptionnelles et épigénétiques dans les déficits comportementaux de la maladie de Huntington
    Caroline Lotz · 2019 · theses.fr (ABES)
  30. Identification of genetic modifiers in Hereditary Spastic Paraplegias due to SPAST/SPG4 mutations
    Livia Parodi · 2019
  31. Distinct autophagy impairment mechanisms of huntingtin aggregates with different polyQ lengths
    Heejung Kim, Hae Nim Lee, S S Kim, Seung Jae Hyeon, Hyunmin Jo, Kyung‐Soo Inn, Hoon Ryu, J Y Seong · 2026 · Cell chemical biology
  32. Functional impacts of Huntingtin lowering on the synaptic maturation and activity of neuronal networks derived from human induced pluripotent stem cells
    Mathilde Louçã · 2024 · theses.fr (ABES)
  33. Personalized health predictions challenge existing insurance frameworks: Time to revisit life and disability insurance regulation?
    Max J. Rensink, Maartje Schermer, Ineke L L E Bolt · 2026 · Journal of Genetic Counseling
  34. Towards AI-driven prediction of HTT CAG size in super-expanded human spiny projection neurons from Huntington disease donors
    Simone Maestri, Davide Scalzo, Martina Zobel, Dario Besusso, Elena F. Cattaneo · 2026 · Journal of Huntington s Disease
  35. Section 5
    Kenneth S. Kendler, Josef Parnas, Peter Zachar · 2026 · Cambridge University Press eBooks
  36. Commentary on Turkheimer and Kaplan’s “Stalking the Wild Quincunx”
    Steven E. Hyman · 2026 · Cambridge University Press eBooks
  37. Experimental Models of Polyglutamine Disorders
    Parvathi Satheesh, Jan Tuma · 2026 · Contemporary clinical neuroscience
  38. The holistic burden of Huntington's disease: A qualitative study of multigenerational impact on individuals and family caregivers across Europe
    Charlie Albert Smith, Savita Bakhshi Anand, Astri Arnesen, Cecilia Jimenez‐Moreno, Charles P. Khoury, Helen Luck, Joshua Trivlidis, Doorsa Tarazi, Mai-lise Nguyen, Anna Kotzeva et al. · 2026 · Journal of Huntington s Disease
  39. Clinical implications of loss of interruption variants for diagnosis, genetic counselling, and clinical trials in Huntington's disease
    Hailey Findlay Black, Jessica Dawson, Chris Kay, Stephanie Bortnick, Kyla Javier, Michael R. Hayden · 2026 · Journal of Huntington s Disease
  40. Genetic or pharmacological disruption of the MSH3 Y245/K246 IDL binding pocket slows CAG repeat expansion
    Rob Goold, Jasmine Donaldson, Florence Gidney, Philip Goff, Joseph Hamilton, Marwa Elmasri, Lucy Coupland, Michael D. Flower, Sarah J. Tabrizi · 2026 · NAR Molecular Medicine
  41. Individuals who deviate from polygenic expectation are enriched for damaging variants in genes linked to rare disease
    Nikolas A. Baya, Frederik Heymann Lassen, Barney Hill, Samvida S. Venkatesh, Hannah Currant, Cecilia M. Lindgren, Duncan S. Palmer · 2026 · The American Journal of Human Genetics
  42. Childhood to Adult Neurodevelopment in Gene-Expanded Huntington’s Disease (ChANGE-HD): A prospective longitudinal neurodevelopmental study of Huntington’s disease
    Mohit Neema, Nabil M Halabi, Peg Nopoulos, Michael Freedberg, the ChANGE-HD investigators, coordinators, and consultants · 2026 · PLoS ONE
  43. Reconciling the effects of PMS2 in different repeat expansion disease models supports a common expansion mechanism
    Carson J. Miller, Diego Antonio Jimenez, Alexandra Walker, Kusala Anupindi, Bruce E. Hayward, Hernán Lorenzi, Karen Usdin, Xiao-Nan Zhao · 2026 · PNAS Nexus
  44. Advances in diffusion MRI in Huntington's disease
    Claudia Metzler‐Baddeley, Arnau Puig‐Davi, Estela Càmara, Ruth de Diego‐Balaguer, Frederic Sampedro · 2026 · Elsevier eBooks
  45. WWOX contributes to DNA damage, but not somatic instability in Huntington’s disease
    Tiziana Petrozziello, Zachariah L. McLean, Adel Boudi, Sommer S. Huntress, Eric J. Granucci, Grace A Field, Ranee Zara B. Monsanto, Ayleen L. Castillo Torres, Jennie C. L. Roy, Maheswaran Kesavan et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  46. Update on Genetic Chorea
    Miriam Ostrožovičová, Matěj Škorvánek · 2026 · Current Neurology and Neuroscience Reports
  47. Structural insights into the MLH1–FAN1 interaction reveal an uncharacterized binding interface on MLH1
    Yichang Chen, Haiyun Hu, Xinci Shang, Keri M. Fishwick, Giada Greco, Qin Xiao, Yinhao Zhou, Qiuyan Huang, T Jiang, XJ Huang et al. · 2026 · Nature Communications
  48. Huntington's disease in the era of somatic instability, biomarkers, and targeted therapies: A narrative review
    Amin Cervantes‐Arriaga, Ashley Xanat Beltrán Torres, Diego Romero-García, Mayela Rodríguez‐Violante · 2026 · Revista de investigaci�n Cl�nica
  49. Enhancing the detection of HTT1a with neoepitope antibodies in mouse models of Huntington’s disease
    Georgina F Osborne, Edward J. Smith, Kirupa Sathasivam, Zixin Kang, Iulia M Nita, María Cañibano-Pico, Jemima M Phillips, Gillian P. Bates, Christian Landles · 2026 · Brain Communications
  50. Decoding neuronal vulnerability: Multidimensional analysis of D1R ‐ and D2R ‐ medium‐sized spiny neurons in Huntington's disease
    Guendalina Bergonzoni, Miguel Pellegrini, Aurora Savino, Martina Lazioli, Sarah Geurs, Lorenzo Graziani, Denise Ferrarini, Solaleh Khoramian Tusi, Esaria Oliver, Jarne Geurts et al. · 2026 · Brain Pathology
  51. Effects of time-restricted eating in early-stage Huntington’s disease: a pilot study
    Russell G. Wells, Lee E. Neilson, Andrew W. McHill, Nora E. Gray, Joseph F. Quinn, Amie Hiller · 2026 · Nature Metabolism
  52. Gene therapy in Huntington’s disease (HD)
    Fatemeh Tirgar, Mina Hosseini, Sakineh Alijanpour, Mohamad-Reza Aghanoori, Sahar Alijanpour, Hami Mahdavinataj · 2026 · Elsevier eBooks
  53. Redundant mispair excision mechanisms in eukaryotic DNA mismatch repair
    Christopher D. Putnam, Richard David Kolodner · 2026 · Nucleus
  54. Directing mutant huntingtin towards degradation: Strategies and therapeutic opportunities
    Florence D.M. Wavreil, Sabine Schipper-Krom, Eric A. Reits · 2026 · Journal of Huntington s Disease
  55. Large-scale pooled selection enables mapping of modifiers of RNAi gene knockdown effects in C. elegans
    Stefan Zdraljevic, Alex Lee, Laura Walter-McNeill, Heriberto Marquez, Amy K. Webster, Rojin Chitrakar, Jameson Blount, L. Ryan Baugh, Joshua S. Bloom, Leonid Kruglyak · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  56. AAV5-miHTT (AMT-130) gene therapy for Huntington's disease: A review of mechanisms and phase I/II clinical trial evidence
    Arpan Pathak, Monika Sharma, Ankit Pant, Aarushi Singh, Harsh Srivastava, Priya, Manoj Gadewar, Debashish Paramanick · 2026 · Gene Reports
  57. Neurofilament Light Chain and Mutant Huntingtin Across Huntington's Disease Integrated Staging System Stages in Huntington Disease: A Cross‐Sectional Multimodal Analysis
    Jesús Pérez‐Pérez, Gonzalo Olmedo‐Saura, Arnau Puig‐Davi, Rocío Pérez‐González, Jordi Pegueroles, Andrea Horta‐Barba, Anna Vázquez Oliver, Elisa I. Rivas, Daniel Andres Alcolea, Juan Fortea et al. · 2026 · Movement Disorders
  58. Key Resource Table: Dynamic convergence of neurodevelopmental disorder risk genes across neurodevelopment
    Kristen Brennand · 2026 · Zenodo (CERN European Organization for Nuclear Research)
  59. Somatic DNA-repeat expansions initiate distinct yet analogous changes in Huntington’s disease cortical and striatal neurons
    Seva Kashin, Won‐Seok Lee, Tara M. McDonald, Kiely Morris, Robert E. Handsaker, Curtis J. Mello, Liv Spina, Nora M. Reed, Heather de Rivera, Sri Havya Jana et al. · 2026 · Cell